Paylocity Holding Corp
For the period ended Mar 31, 2024. Filed May 3, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 3, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to the Unaudited Consolidated Financial Statements
(all amounts in thousands, except per share data)
(1) Organization and Description of Business
Paylocity Holding Corporation (the “Company”) is a cloud-based provider of human capital management and payroll software solutions that deliver a comprehensive platform for the modern workforce. Services are provided in a Software-as-a-Service (“SaaS”) delivery model. The Company’s comprehensive product suite delivers a unified platform that helps businesses attract and retain talent, build culture and connection with their employees, and streamline and automate HR and payroll processes.
(2) Summary of Significant Accounting Policies
(a)Basis of Presentation, Consolidation and Use of Estimates
These unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). The unaudited consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.
The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Future events and their effects cannot be predicted with certainty; accordingly, accounting estimates require the exercise of judgment. Accounting estimates used in the preparation of these consolidated financial statements may change as new events occur, as more experience is acquired, as additional information is obtained and as the operating environment changes.
(b)Interim Unaudited Consolidated Financial Information
The accompanying unaudited consolidated financial statements and notes have been prepared in accordance with GAAP and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, the interim financial information includes all adjustments of a normal recurring nature necessary for a fair presentation of the Company’s financial position, results of operations, changes in stockholders’ equity and cash flows. The results of operations for the three and nine months ended March 31, 2024 are not necessarily indicative of the results for the full year or the results for any future periods. These unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes for the year ended June 30, 2023 included in the Company’s Annual Report on Form 10-K.
(c)Income Taxes
Income taxes are accounted for in accordance with ASC 740, Income Taxes, using the asset and liability method. The Company’s provision for income taxes is based on the annual effective rate method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.
The Company recognizes deferred tax assets to the extent that it believes that these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If the Company determines that it would be able to realize its deferred tax assets in the future in excess of their net-recorded amount, it would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.
(d)Recently Issued Accounting Standards
In November 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures ("ASU 2023-07"). ASU 2023-07 primarily requires disclosure of significant segment expenses that are regularly provided to the chief operating decision maker along with other incremental segment information. The ASU is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted, and will be applied retrospectively to all prior periods presented in the financial statements. The Company is currently assessing the impact of this ASU to its consolidated financial statements and related disclosures and is evaluating the timing of adoption.
In December 2023, the FASB issued Accounting Standards Update 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosure ("ASU 2023-09"). ASU 2023-09 mostly requires, on an annual basis, disclosure of specific categories in an entity's effective tax rate reconciliation and income taxes paid disaggregated by jurisdiction. The incremental disclosures may be presented on a prospective or retrospective basis. The ASU is effective for fiscal years beginning after December 15, 2024 with early adoption permitted. The Company is currently assessing the impact of this ASU to its consolidated financial statements and related disclosures and is evaluating the method and timing of adoption.
From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board or other standard-setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of other recently issued standards that are not yet effective will not have a material impact on the Company’s consolidated financial statements upon adoption.
(3) Revenue
The Company derives its revenue from contracts predominantly from recurring service fees. While the majority of its agreements are generally cancellable by the client on 60 days’ notice or less, the Company also offers term agreements to its clients, which are generallytwo years in length. Recurring fees are derived from payroll, timekeeping, and HR-related cloud-based computing services. The majority of the Company’s recurring fees are satisfied over time as services are provided. The performance obligations related to payroll services are satisfied upon the processing of the client’s payroll with the fee charged and collected based on a per employee per payroll frequency fee. The performance obligations related to time and attendance services and HR related services are satisfied over time each month with the fee charged and collected based on a per employee per month fee. For subscription-based fees which can include payroll, time and attendance, and other HCM related services, the Company recognizes the applicable recurring fees over time each month with the fee charged and collected based on a per employee per month fee. Implementation services and other consist mainly of nonrefundable implementation fees, which involve setting the client up in, and loading data into, the Company’s cloud-based modules. These implementation activities are considered set-up activities. The Company has determined that the nonrefundable upfront fees provide certain clients with a material right to renew the contract.
Disaggregation of revenue
The following table disaggregates total revenues from contracts by Recurring fees and Implementation services and other, which the Company believes depicts the nature, amount and timing of its revenue:
| Three Months EndedMarch 31, | Nine Months EndedMarch 31, | |||
|---|---|---|---|---|
| 2023 | 2024 | 2023 | 2024 | |
| Recurring fees | $302,595 | $352,025 | $786,936 | $917,064 |
| Implementation services and other | 11,575 | 14,815 | 29,074 | 39,877 |
| Total revenues from contracts | $314,170 | $366,840 | $816,010 | $956,941 |
Deferred revenue
The timing of revenue recognition for recurring revenue is consistent with the timing of invoicing as they occur simultaneously based on the client payroll processing period or by month. As such, the Company does not recognize contract assets or liabilities related to recurring revenue.
The Company defers and amortizes nonrefundable upfront fees related to implementation services generally over a period up to 24 months based on the type of contract. The following table summarizes the changes in deferred revenue (i.e., contract liability) related to these nonrefundable upfront fees as follows:
| Three Months EndedMarch 31, | Nine Months EndedMarch 31, | |||
|---|---|---|---|---|
| 2023 | 2024 | 2023 | 2024 | |
| Balance at beginning of the period | $19,737 | $26,245 | $12,233 | $22,617 |
| Deferral of revenue | 10,211 | 10,932 | 30,445 | 33,164 |
| Revenue recognized | (8,589) | (11,324) | (21,319) | (29,928) |
| Balance at end of the period | $21,359 | $25,853 | $21,359 | $25,853 |
Deferred revenue related to these nonrefundable upfront fees are recorded within Accrued expenses and Other long-term liabilities on the Unaudited Consolidated Balance Sheets. The Company expects to recognize these deferred revenue balances of $10,442 in fiscal 2024, $13,048 in fiscal 2025 and $2,363 in fiscal 2026 and thereafter.
Deferred contract costs
The Company defers certain selling and commission costs that meet the capitalization criteria under ASC 340-40. The Company also capitalizes certain costs to fulfill a contract related to its proprietary products if they are identifiable, generate or enhance resources used to satisfy future performance obligations and are expected to be recovered under ASC 340-40. Implementation fees are treated as nonrefundable upfront fees and the related implementation costs are required to be capitalized and amortized over the expected period of benefit, which is the period in which the Company expects to recover the costs and enhance its ability to satisfy future performance obligations.
The Company utilizes the portfolio approach to account for both the cost of obtaining a contract and the cost of fulfilling a contract. These capitalized costs are amortized over the expected period of benefit, which has been determined to be over 7 years based on the Company’s average client life and other qualitative factors, including rate of technological changes. The Company does not incur any additional costs to obtain or fulfill contracts upon renewal. The Company recognizes additional selling and commission costs and fulfillment costs when an existing client purchases additional services. These additional costs only relate to the additional services purchased and do not relate to the renewal of previous services.
The following tables present the deferred contract costs and the related amortization expense for these deferred contract costs:
| Three Months Ended March 31, 2023 | ||||
|---|---|---|---|---|
| Beginning Balance | Capitalized Costs | Amortization | Ending Balance | |
| Costs to obtain a new contract | $200,553 | $22,105 | $(11,477) | $211,181 |
| Costs to fulfill a contract | 130,317 | 19,085 | (6,699) | 142,703 |
| Total | $330,870 | $41,190 | $(18,176) | $353,884 |
| Three Months Ended March 31, 2024 | ||||
|---|---|---|---|---|
| Beginning Balance | Capitalized Costs | Amortization | Ending Balance | |
| Costs to obtain a new contract | $230,057 | $23,878 | $(13,408) | $240,527 |
| Costs to fulfill a contract | 174,923 | 19,806 | (9,413) | 185,316 |
| Total | $404,980 | $43,684 | $(22,821) | $425,843 |
| Nine Months Ended March 31, 2023 | ||||
|---|---|---|---|---|
| Beginning Balance | Capitalized Costs | Amortization | Ending Balance | |
| Costs to obtain a new contract | $182,543 | $61,327 | $(32,689) | $211,181 |
| Costs to fulfill a contract | 106,025 | 54,750 | (18,072) | 142,703 |
| Total | $288,568 | $116,077 | $(50,761) | $353,884 |
| Nine Months Ended March 31, 2024 | ||||
|---|---|---|---|---|
| Beginning Balance | Capitalized Costs | Amortization | Ending Balance | |
| Costs to obtain a new contract | $218,965 | $60,214 | $(38,652) | $240,527 |
| Costs to fulfill a contract | 153,366 | 58,066 | (26,116) | 185,316 |
| Total | $372,331 | $118,280 | $(64,768) | $425,843 |
Deferred contract costs are recorded within Deferred contract costs and Long-term deferred contract costs on the Unaudited Consolidated Balance Sheets. Amortization of deferred contract costs is primarily recorded in Cost of revenues and Sales and marketing in the Unaudited Consolidated Statements of Operations and Comprehensive Income.
Remaining Performance Obligations
The balance of the Company’s remaining performance obligations related to minimum monthly fees on its term-based contracts was approximately $74,270 as of March 31, 2024, which will be generally recognized over the next 24 months. This balance excludes the value of unsatisfied performance obligations for contracts that have an original expected duration of one year or less and contracts for which the variable consideration is allocated entirely to wholly unsatisfied performance obligations.
(4) Business Combination
On November 30, 2023, the Company acquired all of the outstanding shares of TraceHQ.com, Inc. ("Trace") through a merger of Trace with a subsidiary of the Company for cash consideration of $12,086, subject to working capital and other customary purchase price adjustments. Trace offers a headcount planning solution that expands the Company's product functionality in this area. The preliminary allocation of the purchase price for Trace was approximately $6,473 of goodwill, $4,200 of proprietary technology and other immaterial assets and liabilities which reflects certain immaterial measurement period adjustments recorded during the three months ended March 31, 2024. The Company accounted for this transaction as a business combination and recorded the assets acquired and liabilities assumed at their respective estimated fair values as of the date of the acquisition with the excess consideration paid recorded as goodwill. The fair values of the assets acquired and liabilities assumed are currently provisional and are subject to change over the measurement period as the Company continues to evaluate and analyze the estimates and assumptions used in the valuation. The measurement period will end no later than one year from the acquisition date.
The results from this acquisition have been included in the Company’s consolidated financial statements since the closing of the transaction and are not material to the Company. Pro forma information is not presented because the effects of the acquisition are not material to the Company’s consolidated financial statements. The goodwill related to this transaction is primarily attributable to the assembled workforce and growth opportunities from the expansion and enhancement of the Company’s product offerings. The goodwill associated with the Trace acquisition is not deductible for income tax purposes. Direct costs related to the acquisition were immaterial and were expensed as incurred as General and administrative expense in the Unaudited Consolidated Statements of Operations and Comprehensive Income.
(5) Balance Sheet Information
The following tables provide details of selected consolidated balance sheet items:
Activity in the allowance for credit losses related to accounts receivable was as follows:
| Balance at June 30, 2023 | $1,620 |
|---|---|
| Charged to expense | 713 |
| Write-offs | (525) |
| Balance at March 31, 2024 | $1,808 |
Capitalized internal-use software and accumulated amortization were as follows:
| June 30,2023 | March 31,2024 | |
|---|---|---|
| Capitalized internal-use software | $248,738 | $305,763 |
| Accumulated amortization | (162,611) | (195,082) |
| Capitalized internal-use software, net | $86,127 | $110,681 |
Amortization of capitalized internal-use software costs is primarily included in Cost of revenues and amounted to $7,984 and $12,260 for the three months ended March 31, 2023 and 2024, respectively, and $22,504 and $32,471 for the nine months ended March 31, 2023 and 2024, respectively.
The major classes of property and equipment, net were as follows:
| June 30,2023 | March 31,2024 | |
|---|---|---|
| Office equipment | $2,508 | $2,792 |
| Computer equipment | 58,670 | 61,624 |
| Furniture and fixtures | 12,958 | 12,986 |
| Software | 11,127 | 12,812 |
| Leasehold improvements | 48,159 | 48,872 |
| Time clocks rented by clients | 8,533 | 9,526 |
| Total | 141,955 | 148,612 |
| Accumulated depreciation | (77,886) | (87,839) |
| Property and equipment, net | $64,069 | $60,773 |
Depreciation expense amounted to $4,633 and $5,220 for the three months ended March 31, 2023 and 2024, respectively, and $13,666 and $15,449 for the nine months ended March 31, 2023 and 2024, respectively.
The following table summarizes changes in goodwill during the nine months ended March 31, 2024:
| March 31,2024 | |
|---|---|
| Balance at June 30, 2023 | $102,054 |
| Addition attributable to acquisition | 6,473 |
| Balance at March 31, 2024 | $108,527 |
Refer to Note 4 for further details on current year acquisition activity.
The Company’s amortizable intangible assets and estimated useful lives are as follows:
| June 30,2023 | March 31,2024 | Weighted average useful life (years) | |
|---|---|---|---|
| Proprietary technology | $43,129 | $47,329 | 5.9 |
| Client relationships | 22,200 | 22,200 | 7.8 |
| Non-solicitation agreements | 1,600 | 1,600 | 3.1 |
| Trade names | 1,640 | 1,640 | 5.0 |
| Total | 68,569 | 72,769 | |
| Accumulated amortization | (34,042) | (41,901) | |
| Intangible assets, net | $34,527 | $30,868 |
Amortization expense for acquired intangible assets was $2,770 and $2,798 for the three months ended March 31, 2023 and 2024, respectively, and $8,311 and $7,859 for the nine months ended March 31, 2023 and 2024, respectively, and is included in Cost of revenues and General and administrative.
Future amortization expense for acquired intangible assets as of March 31, 2024 is as follows:
| Remainder of fiscal 2024 | $2,577 |
|---|---|
| Fiscal 2025 | 9,728 |
| Fiscal 2026 | 8,109 |
| Fiscal 2027 | 5,733 |
| Fiscal 2028 | 3,869 |
| Thereafter | 852 |
| Total | $30,868 |
The components of accrued expenses were as follows:
| June 30,2023 | March 31,2024 | |
|---|---|---|
| Accrued payroll and personnel costs | $85,019 | $95,787 |
| Operating lease liabilities | 7,800 | 8,021 |
| Deferred revenue | 24,539 | 27,544 |
| Other | 25,929 | 39,223 |
| Total accrued expenses | $143,287 | $170,575 |
(6) Corporate Investments and Funds Held for Clients
Corporate investments and funds held for clients consisted of the following:
| Type of Issue | Amortized cost | Gross unrealized gains | Gross unrealized losses | Fair value |
|---|---|---|---|---|
| Cash and cash equivalents | $288,767 | $— | $— | $288,767 |
| Funds held for clients' cash and cash equivalents | 2,132,545 | — | — | 2,132,545 |
| Available-for-sale securities: | ||||
| Commercial paper | 110,003 | 12 | (138) | 109,877 |
| Corporate bonds | 112,262 | 18 | (1,867) | 110,413 |
| Asset-backed securities | 30,061 | 10 | (337) | 29,734 |
| Certificates of deposit | 68,247 | 5 | (93) | 68,159 |
| U.S. treasury securities | 158,839 | — | (2,839) | 156,000 |
| U.S government agency securities | 8,000 | — | (513) | 7,487 |
| Other | 7,329 | — | (129) | 7,200 |
| Total available-for-sale securities | 494,741 | 45 | (5,916) | 488,870 |
| Total investments | $2,916,053 | $45 | $(5,916) | $2,910,182 |
| Type of Issue | Amortized cost | Gross unrealized gains | Gross unrealized losses | Fair value |
|---|---|---|---|---|
| Cash and cash equivalents | $492,695 | $— | $— | $492,695 |
| Funds held for clients' cash and cash equivalents | 3,084,470 | — | — | 3,084,470 |
| Available-for-sale securities: | ||||
| Commercial paper | 14,343 | — | (4) | 14,339 |
| Corporate bonds | 256,027 | 1,557 | (895) | 256,689 |
| Asset-backed securities | 38,300 | 185 | (149) | 38,336 |
| Certificates of deposit | 13,420 | 11 | — | 13,431 |
| U.S. treasury securities | 164,478 | 60 | (1,232) | 163,306 |
| U.S government agency securities | 8,000 | — | (271) | 7,729 |
| Other | 12,820 | 119 | (41) | 12,898 |
| Total available-for-sale securities | 507,388 | 1,932 | (2,592) | 506,728 |
| Total investments | $4,084,553 | $1,932 | $(2,592) | $4,083,893 |
All available-for-sale securities were included in Funds held for clients at June 30, 2023 and March 31, 2024.
Cash and cash equivalents and funds held for clients’ cash and cash equivalents included demand deposit accounts and money market funds at June 30, 2023 and March 31, 2024.
Classification of investments on the Unaudited Consolidated Balance Sheets was as follows:
| June 30,2023 | March 31, 2024 | |
|---|---|---|
| Cash and cash equivalents | $288,767 | $492,695 |
| Funds held for clients | 2,621,415 | 3,591,198 |
| Total investments | $2,910,182 | $4,083,893 |
Available-for-sale securities that had been in an unrealized loss position for a period of less and greater than 12 months as of June 30, 2023 and March 31, 2024 had fair market value as follows:
| Securities in an unrealized lossposition for less than 12 months | Securities in an unrealized lossposition for greater than 12 months | Total | ||||
|---|---|---|---|---|---|---|
| Gross unrealized losses | Fair value | Gross unrealized losses | Fair value | Gross unrealized losses | Fair value | |
| Commercial paper | $(138) | $96,665 | $— | $— | $(138) | $96,665 |
| Corporate bonds | (695) | 71,089 | (1,172) | 32,807 | (1,867) | 103,896 |
| Asset-backed securities | (233) | 23,313 | (104) | 2,038 | (337) | 25,351 |
| Certificates of deposit | (93) | 52,254 | — | — | (93) | 52,254 |
| U.S. treasury securities | (1,075) | 95,388 | (1,764) | 60,612 | (2,839) | 156,000 |
| U.S. government agency securities | — | — | (513) | 7,487 | (513) | 7,487 |
| Other | (71) | 5,326 | (58) | 1,874 | (129) | 7,200 |
| Total available-for-sale securities | $(2,305) | $344,035 | $(3,611) | $104,818 | $(5,916) | $448,853 |
| Securities in an unrealized lossposition for less than 12 months | Securities in an unrealized lossposition for greater than 12 months | Total | ||||
|---|---|---|---|---|---|---|
| Gross unrealized losses | Fair value | Gross unrealized losses | Fair value | Gross unrealized losses | Fair value | |
| Commercial paper | $(4) | $14,339 | $— | $— | $(4) | $14,339 |
| Corporate bonds | (339) | 77,014 | (556) | 25,194 | (895) | 102,208 |
| Asset-backed securities | (2) | 3,877 | (147) | 8,102 | (149) | 11,979 |
| U.S. treasury securities | (506) | 88,119 | (726) | 68,205 | (1,232) | 156,324 |
| U.S. government agency securities | — | — | (271) | 7,729 | (271) | 7,729 |
| Other | (9) | 2,785 | (32) | 3,614 | (41) | 6,399 |
| Total available-for-sale securities | $(860) | $186,134 | $(1,732) | $112,844 | $(2,592) | $298,978 |
The Company regularly reviews the composition of its portfolio to determine the existence of credit impairment. The Company didnot recognize any credit impairment losses during the three or nine months ended March 31, 2023 or 2024. All securities in the Company’s portfolio held an A-1 rating or better as of March 31, 2024.
The Company did not make any material reclassification adjustments out of accumulated other comprehensive income for realized gains and losses on the sale of available-for-sale securities during the three or nine months ended March 31, 2023 or 2024. There wereno realized gains or losses on the sale of available-for-sale securities for the three or nine months ended March 31, 2023 or 2024.
Expected maturities of available-for-sale securities at March 31, 2024 were as follows:
| Amortized cost | Fair value | |
|---|---|---|
| One year or less | $195,435 | $194,520 |
| One year to two years | 130,594 | 129,364 |
| Two years to three years | 57,927 | 58,282 |
| Three years to five years | 123,432 | 124,562 |
| Total available-for-sale securities | $507,388 | $506,728 |
(7) Fair Value Measurement
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy prioritizes the inputs used to measure fair value. The hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:
Level 1—Quoted prices in active markets for identical assets and liabilities.
Level 2—Quoted prices in active markets for similar assets and liabilities, or other inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets and liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.
The Company measures certain cash and cash equivalents, funds held for clients' cash and cash equivalents, accounts receivable, accounts payable and client fund obligations at fair value on a recurring basis using Level 1 inputs. The Company considers the recorded value of these financial assets and liabilities to approximate the fair value of the respective assets and liabilities at June 30, 2023 and March 31, 2024 based upon the short-term nature of these assets and liabilities.
Marketable securities, consisting of securities classified as available-for-sale as well as certain cash equivalents, are recorded at fair value on a recurring basis using Level 2 inputs obtained from an independent pricing service. Available-for-sale securities include commercial paper, corporate bonds, asset-backed securities, certificates of deposit, U.S. treasury securities, U.S. government agency and other securities. The independent pricing service utilizes a variety of inputs including benchmark yields, broker/dealer quoted prices, reported trades, issuer spreads as well as other available market data. The Company, on a sample basis, validates the pricing from the independent pricing service against another third-party pricing source for reasonableness. The Company has not adjusted any prices obtained by the independent pricing service, as it believes they are appropriately valued. There wereno available-for-sale securities classified in Level 3 of the fair value hierarchy at June 30, 2023 or March 31, 2024.
The fair value level for the Company’s cash and cash equivalents and available-for-sale securities was as follows:
| June 30, 2023 | ||||
|---|---|---|---|---|
| Total | Level 1 | Level 2 | Level 3 | |
| Cash and cash equivalents | $288,767 | $288,767 | $— | $— |
| Funds held for clients' cash and cash equivalents | 2,132,545 | 2,132,545 | — | — |
| Available-for-sale securities: | ||||
| Commercial paper | 109,877 | — | 109,877 | — |
| Corporate bonds | 110,413 | — | 110,413 | — |
| Asset-backed securities | 29,734 | — | 29,734 | — |
| Certificates of deposit | 68,159 | — | 68,159 | — |
| U.S. treasury securities | 156,000 | — | 156,000 | — |
| U.S government agency securities | 7,487 | — | 7,487 | — |
| Other | 7,200 | — | 7,200 | — |
| Total available-for-sale securities | 488,870 | — | 488,870 | — |
| Total investments | $2,910,182 | $2,421,312 | $488,870 | $— |
| March 31, 2024 | ||||
|---|---|---|---|---|
| Total | Level 1 | Level 2 | Level 3 | |
| Cash and cash equivalents | $492,695 | $492,695 | $— | $— |
| Funds held for clients' cash and cash equivalents | 3,084,470 | 3,084,470 | — | — |
| Available-for-sale securities: | ||||
| Commercial paper | 14,339 | — | 14,339 | — |
| Corporate bonds | 256,689 | — | 256,689 | — |
| Asset-backed securities | 38,336 | — | 38,336 | — |
| Certificates of deposit | 13,431 | — | 13,431 | — |
| U.S. treasury securities | 163,306 | — | 163,306 | — |
| U.S government agency securities | 7,729 | — | 7,729 | — |
| Other | 12,898 | — | 12,898 | — |
| Total available-for-sale securities | 506,728 | — | 506,728 | — |
| Total investments | $4,083,893 | $3,577,165 | $506,728 | $— |
Assets and Liabilities Recorded at Fair Value on a Non-Recurring Basis
The Company records assets acquired and liabilities assumed in business combinations at fair value. Refer to Note 4 for further details on the fair value measurements of certain assets and liabilities recorded at fair value on a non-recurring basis.
(8) Debt
In July 2019, the Company entered into a revolving credit agreement with PNC Bank, National Association, and other lenders, which is secured by substantially all of the Company’s assets, subject to certain restrictions. In August 2022, the Company entered into a first amendment to the aforementioned credit agreement to increase the borrowing capacity of our revolving credit facility ("credit facility") to $550,000, which may be increased up to $825,000, subject to obtaining additional lender commitments and certain approvals and satisfying other requirements. The amended credit agreement extends the maturity date of the credit facility to August 2027 and replaces the interest rate based on London Interbank Offered Rate with an interest rate based on secured overnight financing rate ("SOFR"). The Company hadno borrowings at June 30, 2023 or March 31, 2024.
The proceeds of any borrowings are to be used to fund working capital, capital expenditures and general corporate purposes, including permitted acquisitions, permitted investments, permitted distributions and share repurchases. The Company may generally borrow, prepay and reborrow under the credit facility and terminate or reduce the lenders’
commitments at any time prior to revolving credit facility expiration without a premium or a penalty, other than customary “breakage” costs.
Any borrowings under the credit facility will generally bear interest, at the Company’s option, at a rate per annum determined by reference to either the Term SOFR rate plus the SOFR Adjustment or an adjusted base rate, in each case plus an applicable margin ranging from 0.875% to 1.500% and 0.0% to 0.500%, respectively, based on the then-applicable net total leverage ratio. Additionally, the Company is required to pay certain commitment, letter of credit fronting and letter of credit participation fees on available and/or undrawn portions of the credit facility.
The Company is required to comply with certain customary affirmative and negative covenants, including a requirement to maintain a maximum net total leverage ratio of not greater than 4.00 to 1.00, (with a step up to 4.50 to 1.00 for the 4 consecutive fiscal quarters following a fiscal quarter in which certain permitted acquisitions are consummated), and a minimum interest coverage ratio of not less than 2.00 to 1.00. As of March 31, 2024, the Company was in compliance with all of the aforementioned covenants.
(9) Stock-Based Compensation
In November 2023, the Company’s stockholders approved the 2023 Equity Incentive Plan (the “2023 Plan”). The 2023 Plan serves as the successor to the 2014 Equity Incentive Plan (the “2014 Plan”) and permits the granting of restricted stock units ("RSUs"), market share units ("MSUs") and other equity incentives at the discretion of the compensation committee of the Company’s board of directors. No new awards have been or will be issued under the 2014 Plan since the effective date of the 2023 Plan. Outstanding awards under the 2014 Plan continue to be subject to the terms and conditions of the 2014 Plan.
As of March 31, 2024, the Company had 2,090 shares available for future grant under the 2023 Plan, and 1,766 shares were subject to outstanding options or awards. Generally, the Company issues previously unissued shares for the exercise of stock options or vesting of awards; however, shares previously subject to granted awards that are forfeited or net settled at exercise or release may be reissued under the 2023 Plan to satisfy future issuances.
Stock-based compensation expense related to RSUs, MSUs and the Employee Stock Purchase Plan is included in the following line items in the accompanying unaudited consolidated statements of operations and comprehensive income:
| Three Months Ended March 31, | Nine Months Ended March 31, | |||
|---|---|---|---|---|
| 2023 | 2024 | 2023 | 2024 | |
| Cost of revenues | $4,187 | $4,527 | $13,460 | $14,945 |
| Sales and marketing | 8,789 | 9,079 | 29,143 | 28,347 |
| Research and development | 8,665 | 7,427 | 28,759 | 28,498 |
| General and administrative | 10,997 | 13,919 | 44,640 | 45,375 |
| Total stock-based compensation expense | $32,638 | $34,952 | $116,002 | $117,165 |
In addition, the Company capitalized $2,888 and $3,470 of stock-based compensation expense in its capitalized internal-use software costs in the three months ended March 31, 2023 and 2024, respectively, and $8,984 and $11,435 for the nine months ended March 31, 2023 and 2024, respectively.
There wereno stock options granted during the nine months ended March 31, 2024. The table below presents stock option activity during the nine months ended March 31, 2024:
| Outstanding Options | ||||
|---|---|---|---|---|
| Number of shares | Weighted average exercise price | Weighted average remaining contractual term (years) | Aggregate intrinsic value | |
| Option balance at July 1, 2023 | 288 | $23.63 | 1.2 | $46,129 |
| Options exercised | (118) | $17.24 | ||
| Option balance at March 31, 2024 | 170 | $28.09 | 0.7 | $24,268 |
| Options vested and exercisable at March 31, 2024 | 170 | $28.09 | 0.7 | $24,268 |
The total intrinsic value of options exercised was $2,011 and $13,476 during the three months ended March 31, 2023 and 2024, respectively, and $51,638 and $18,176 for the nine months ended March 31, 2023 and 2024, respectively.
The Company grants RSUs under its equity incentive plan with terms determined at the discretion of the compensation committee of the Company’s board of directors. RSUs generally vest over four years following the grant date and have time-based vesting conditions.
The following table represents restricted stock unit activity during the nine months ended March 31, 2024:
| Units | Weighted average grant date fair value | |
|---|---|---|
| RSU balance at July 1, 2023 | 1,242 | $225.30 |
| RSUs granted | 781 | $192.77 |
| RSUs vested | (525) | $197.44 |
| RSUs forfeited | (99) | $212.77 |
| RSU balance at March 31, 2024 | 1,399 | $218.49 |
The Company also grants MSUs under its equity incentive plan with terms determined at the discretion of the compensation committee of the Company's board of directors. The actual number of MSUs that will be eligible to vest is based on the achievement of a relative total shareholder return (“TSR”) target as compared to the TSR realized by each of the companies comprising the Russell 3000 Index over an approximately three-year period. The MSUs cliff-vest at the end of the TSR measurement period, and up to 200% of the target number of shares subject to each MSU are eligible to be earned.
The following table represents market share unit activity during the nine months ended March 31, 2024:
| Units · Weighted average grant date fair value | |||
|---|---|---|---|
| MSU balance at July 1, 2023 | 171 | $320.38 | |
| MSUs granted | 86 | $256.66 | |
| MSUs vested | (60) | $178.04 | |
| MSU balance at March 31, 2024 | 197 | $335.79 | |
The Company estimated the grant date fair value of the MSUs using a Monte Carlo simulation model that included the following assumptions:
| Nine Months EndedMarch 31, | ||
|---|---|---|
| 2023 | 2024 | |
| Valuation assumptions: | ||
| Expected dividend yield | —% | —% |
| Expected volatility | 51.0% - 52.7% | 44.5% |
| Expected term (years) | 2.75 - 3.04 | 3.04 |
| Risk‑free interest rate | 3.11% - 4.01% | 4.58% |
At March 31, 2024, there was $161,800 of total unrecognized compensation cost, net of estimated forfeitures, related to unvested RSUs and MSUs. That cost is expected to be recognized over a weighted average period of 1.8 years.
(10) Litigation
On November 16, 2020, a potential class action complaint was filed against the Company with the Circuit Court of Cook County alleging that the Company violated the Illinois Biometric Information Privacy Act. The complaint seeks statutory damages, attorney’s fees and other costs. On September 11, 2023, a second potential class action complaint was filed against the Company with the Circuit Court of Cook County that alleges violations of the Illinois Biometric Information Privacy Act that overlap with claims in the first action. The Company is unable to estimate any reasonably possible loss, or range of loss, with respect to these matters at this time. The Company intends to vigorously defend against these lawsuits.
From time to time, the Company is subject to litigation arising in the ordinary course of business. Many of these matters are covered in whole or in part by insurance. In the opinion of the Company’s management, the ultimate disposition of any matters currently outstanding or threatened will not have a material adverse effect on the Company’s financial position, results of operations, or liquidity. However, these matters are subject to inherent uncertainties and could materially impact the Company’s financial position, results of operations, or liquidity based on the final disposition of these matters.
(11) Income Taxes
The Company’s quarterly provision for income taxes is based on the annual effective rate method. The Company’s quarterly provision for income taxes also includes the tax impact of certain unusual or infrequently occurring items, if any, including changes in judgment about valuation allowances and effects of changes in tax laws or rates, and other discrete items in the interim period in which they occur.
The Company's effective tax rate was 29.3% and 22.9% for the three months ended March 31, 2023 and 2024, respectively. The Company's effective tax rate for the three months ended March 31, 2023 was higher than the federal statutory rate of 21% primarily due to an increase to non-deductible stock-based compensation under Internal Revenue Code Section 162(m) and state and local income taxes. The Company's effective tax rate for the three months ended March 31, 2024 was higher than the federal statutory rate of 21% primarily due to state and local income taxes.
The Company's effective tax rate was 2.9% and 24.3% for the nine months ended March 31, 2023 and 2024, respectively. The Company's effective tax rate for the nine months ended March 31, 2023 was lower than the federal statutory rate of 21% primarily due to excess tax benefits from employee stock-based compensation, research and development tax credits, and a decrease in the valuation allowance. The Company's effective tax rate for the nine months ended March 31, 2024 was higher than the federal statutory rate of 21% primarily due to state and local income taxes.
(12) Net Income Per Share
Basic net income per common share is computed using the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed using the weighted-average number of common shares outstanding during the period and, if dilutive, potential common shares outstanding during the period. The Company’s potential common shares consist of the incremental common shares issuable upon the exercise of stock options, the release of restricted stock units and market share units as of the balance sheet date. The following table presents the calculation of basic and diluted net income per share:
| Three Months EndedMarch 31, | Nine Months EndedMarch 31, | |||
|---|---|---|---|---|
| 2023 | 2024 | 2023 | 2024 | |
| Numerator: | ||||
| Net income | $57,616 | $85,314 | $103,568 | $157,947 |
| Denominator: | ||||
| Weighted-average shares used in computing net income per share: | ||||
| Basic | 55,788 | 56,369 | 55,653 | 56,216 |
| Weighted-average effect of potentially dilutive shares: | ||||
| Employee stock options, restricted stock units and market share units | 767 | 679 | 907 | 759 |
| Diluted | 56,555 | 57,048 | 56,560 | 56,975 |
| Net income per share: | ||||
| Basic | $1.03 | $1.51 | $1.86 | $2.81 |
| Diluted | $1.02 | $1.50 | $1.83 | $2.77 |
The following table summarizes the outstanding restricted stock units and market share units as of March 31, 2023 and 2024 that were excluded from the diluted per share calculation for the periods presented because to include them would have been antidilutive:
| Three Months EndedMarch 31, | Nine Months EndedMarch 31, | |||
|---|---|---|---|---|
| 2023 | 2024 | 2023 | 2024 | |
| Market share units | 26 | 4 | 28 | 19 |
| Restricted stock units | 19 | 4 | 560 | 9 |
| Total | 45 | 8 | 588 | 28 |
(13) Subsequent Events
On April 30, 2024, the Company's Board of Directors approved a share repurchase program (the "Repurchase Program") under which the Company is authorized to purchase (in the aggregate) up to $500,000 of its issued and outstanding common stock. Under the Repurchase Program, shares may be repurchased from time-to-time in open market transactions at prevailing market prices, privately negotiated transactions or by other means, including the use of Rule 10b5-1 trading plans entered into by the Company. The actual timing, number and value of shares repurchased under the Repurchase Program will depend on the market price of its common stock, trading volume, general market conditions and other corporate and economic considerations. The Repurchase Program does not obligate the Company to repurchase any specific number of shares and may be modified, suspended or terminated at any time.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.